Not Losing Weight on Zepbound 15 mg

Most articles on this question were written for people in the middle of dose escalation, and their central recommendation is to talk to your prescriber about going up. At 15 mg that advice has nowhere to go. 15 mg is the maximum maintenance dosage in the Zepbound prescribing information. What follows is written for the top of the ladder.

What 15 mg actually produced in the trial

SURMOUNT-1 randomised 2,539 adults with a BMI of 30 or more, or 27 or more with at least one weight-related complication, excluding diabetes, to tirzepatide 5 mg, 10 mg, 15 mg or placebo for 72 weeks. Mean baseline weight was 104.8 kg and mean BMI was 38.0 (New England Journal of Medicine, 2022).

Three things in that table are worth sitting with. First, the gap between 10 mg and 15 mg is 1.4 percentage points, far smaller than the gap between 5 mg and 10 mg. The dose ladder flattens at the top, so arriving at 15 mg and seeing the scale slow is the expected shape of the curve, not a malfunction. Second, 43 per cent of people on 15 mg did not reach 20 per cent loss, so falling short of the figure in the headlines is the common experience, not the rare one. Third, 9 per cent did not reach even 5 per cent. That is the group for whom "keep waiting" is the wrong answer.

The timeline mistake almost everyone makes

The minus 20.9 per cent figure is a week 72 result, and the trial included a 20-week dose-escalation period before participants were at their assigned dose. So a person who reached 15 mg on the standard four-week-per-step schedule has roughly a year at that dose ahead of them before their timeline matches the trial's endpoint. Comparing a week 24 number to a week 72 number is the single most common reason people conclude the drug has stopped working when it has not.

A decision rule for telling a plateau from a non-response

These are not diagnostic criteria and no guideline issues them in this form. They are a structured way to arrive at a prescriber appointment with an answer rather than a feeling.

Why check 3 is the one that catches people

Of those five, dose consistency is the one people are most confident about and most often wrong about. A weekly injection is easy to lose track of across a holiday, a pharmacy delay or a week when a dose was moved by three days and then moved back. Over a three-month window, two missed weeks is roughly 15 per cent of the intended drug exposure, and it will not feel like anything when recalled from memory.

This is the one part of the problem that a log solves outright. A dose history that shows the actual dates alongside the weight trend turns an argument into a chart. It is also the single most useful thing to put in front of a prescriber who is deciding whether to call this a true non-response. Jabby keeps dose dates, injection sites and weight on one timeline for exactly this.

What is left to change at 15 mg

Dose escalation is off the table, but the inputs around it are not. None of the following is a recommendation to change your treatment, which is your prescriber's decision.

• Protein and resistance training. In the SURMOUNT-1 body composition substudy, about a quarter of the weight lost was lean mass (Diabetes, Obesity and Metabolism, 2025). Losing muscle lowers the energy your body uses at rest, which works against you on the scale. Our Zepbound diet plan is built around that finding.
• Other medications. Several common drug classes are associated with weight gain. This belongs in a medication review with your prescriber or pharmacist, not in self-adjustment.
• Untreated conditions. Thyroid disease, sleep apnoea and other conditions can blunt weight loss. Zepbound itself is now also approved to treat moderate to severe obstructive sleep apnoea in adults with obesity, so this is a question worth asking directly.
• Injection technique and site. Worth confirming against the Instructions for Use rather than assuming. Our guides to injection site choice and KwikPen handling cover what the label actually specifies.

Frequently asked questions

Is 15 mg the highest dose of Zepbound?

Yes. The prescribing information lists 15 mg once weekly as the maximum maintenance dosage. There is no approved step above it, and taking more than the prescribed dose is not a decision to make independently.

How long should I stay at 15 mg before deciding it is not working?

There is no single published threshold, and the answer belongs to your prescriber. What the trial data supports is that the comparison point is week 72 from the first injection, not from reaching 15 mg, and that weight loss in SURMOUNT-1 was still accumulating at the higher doses late in the trial. Several clinical sources suggest reassessing after roughly three to four months at a maintenance dose with minimal response, but that is clinical convention rather than a figure from the label.

Can Zepbound stop working after it worked at first?

Weight loss slowing is expected: as body weight falls, total energy expenditure falls with it, so the same dose produces a smaller deficit over time. That is a plateau and it is normal. A different situation is appetite suppression disappearing entirely while weight climbs. The trial data does not characterise that pattern, so it is a prescriber conversation rather than something to interpret from a web page.

Why am I not losing weight on Zepbound 5 mg?

5 mg is a starting maintenance dosage and produced minus 15.0 per cent at week 72 in SURMOUNT-1, with 85 per cent of people reaching at least 5 per cent loss. At 5 mg, unlike 15 mg, dose escalation genuinely is one of the available options, and the timing of that step is a prescriber decision. Our guide on why and when the dose increases covers the schedule in the label.

Does water retention explain a stalled scale?

Short-term weight changes of one to two kilograms from fluid, food volume and bowel habit are ordinary and can completely mask several weeks of fat loss. This is the reason check 1 above asks for a rolling average rather than a reading. Constipation, which the label reports in 11 per cent of people at 15 mg, contributes to the same effect.

Should I switch to a different GLP-1 if 15 mg is not working?

That is a prescribing decision and depends on your history, insurance coverage and what you have already tried. It is a reasonable question to raise once you have worked through the five checks above and can show a dose history. We do not make switching recommendations here.

Related guides

• Zepbound diet plan: the protein-first structure behind the lean mass finding
• Zepbound maintenance dose after goal weight: what the label says about staying on treatment
• Zepbound 7.5 mg weight loss: the mid-ladder dose and what to expect from it
• How long Zepbound takes to work: the onset timeline from the trials
• GLP-1 weight loss tracker: charting a rolling average instead of reacting to one morning's reading

Sources

• Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 2022. PMID 35658024, DOI 10.1056/NEJMoa2206038, ClinicalTrials.gov NCT04184622. Source for: 2,539 participants; the 72-week duration and 20-week escalation period; mean weight change of minus 15.0, minus 19.5, minus 20.9 and minus 3.1 per cent with confidence intervals; the 85, 89, 91 and 35 per cent figures for at least 5 per cent loss; the 50, 57 and 3 per cent figures for at least 20 per cent loss; mean baseline weight 104.8 kg and BMI 38.0.
• Look M, et al. Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study. Diabetes, Obesity and Metabolism, 2025. PMID 39996356. Source for: approximately 75 per cent of weight lost as fat mass and 25 per cent as lean mass.
• Eli Lilly and Company. ZEPBOUND (tirzepatide) injection prescribing information. Read 8 October 2026. Source for: 15 mg as the maximum maintenance dosage; constipation reported in 11 per cent of people at 15 mg against 5 per cent on placebo; the obstructive sleep apnoea indication.